Zevra Therapeutics, Inc. (ZVRA) Tops Q2 EPS by 16c, beats revenue

Go back to Zevra Therapeutics, Inc. (ZVRA) Tops Q2 EPS by 16c, beats revenue
(NASDAQ: ZVRA) Delayed: 11.32 +0.14 (1.25%)
Previous Close $11.18    52 Week High
Open $11.01    52 Week Low
Day High $11.36    P/E N/A 
Day Low $10.81    EPS
Volume 777,777